Insider · CIK 0001746830
Shefali Agarwal
Files at FATE (FATE THERAPEUTICS INC), GRTS (Gritstone bio, Inc.). First filing -, latest -.
In brief
Shefali Agarwal files SEC Form 4 as director at FATE (FATE THERAPEUTICS INC), and also at GRTS (Gritstone bio, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Shefali Agarwal has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 7 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 12, 2026 | FATE FATE THERAPEUTICS INC | AGrant or award Stock Option (Right to Buy)derivative | +87,900 | $0.00 | $0 | 87,900 | Jun 15, 2026 |
| May 29, 2025 | FATE FATE THERAPEUTICS INC | AGrant or award Stock Option (Right to Buy)derivative | +55,000 | $0.00 | $0 | 55,000 | May 30, 2025 |
| Apr 4, 2025 | GRTS Gritstone bio, Inc. | JOther Stock Option (Right to Buy)derivative | -51,800 | $0.00 | $0 | 0 | Apr 8, 2025 |
| Apr 4, 2025 | GRTS Gritstone bio, Inc. | JOther Stock Option (Right to Buy)derivative | -51,800 | $0.00 | $0 | 0 | Apr 8, 2025 |
| Apr 4, 2025 | GRTS Gritstone bio, Inc. | JOther Stock Option (Right to Buy)derivative | -38,000 | $0.00 | $0 | 0 | Apr 8, 2025 |
| Apr 4, 2025 | GRTS Gritstone bio, Inc. | JOther Stock Option (Right to Buy)derivative | -937 | $0.00 | $0 | 0 | Apr 8, 2025 |
| Apr 4, 2025 | GRTS Gritstone bio, Inc. | JOther Stock Option (Right to Buy)derivative | -19,000 | $0.00 | $0 | 0 | Apr 8, 2025 |
Questions about Shefali Agarwal
Answered from the filings on this page, as of the latest one.
Is Shefali Agarwal buying or selling?
Shefali Agarwal has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Shefali Agarwal's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Shefali Agarwal has 0.
Where does Shefali Agarwal file Form 4?
Shefali Agarwal has filed Form 4 at FATE (FATE THERAPEUTICS INC); GRTS (Gritstone bio, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.